// company-profile

Humacyte, Inc.

HUMA
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings129Insiders21
// api This Humacyte, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 11 insiders purchased shares. Buying was led by Sebelius Kathleen.

// 90-day insight

Over the last 90 days, Humacyte, Inc. insiders bought $60K across 13 transactions with no open-market sales.

  • Most active insider: Sebelius Kathleen with 2 transactions totaling $50K.
  • Largest single purchase: $50K by Sebelius Kathleen on May 19, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Humacyte, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$35.1M
QoQ change
-18.1%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$4.3M
7.2M shares
#2
BlackRock, Inc.
CIK 2012383
$4.3M
7.0M shares
#3
ANTIPODES PARTNERS Ltd
CIK 1652442
$3.5M
5.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Sebelius KathleenHUMA
Award
80,000$0.00$0K
Jun 11, 2026Jones Keith AnthonyHUMA
Award
80,000$0.00$0K
Jun 11, 2026Wallace Max N.HUMA
Award
80,000$0.00$0K
Jun 11, 2026Constantino Michael T.HUMA
Award
80,000$0.00$0K
Jun 11, 2026Niklason Laura EHUMA
Award
80,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.